Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,55 USD | +5,57% | +6,58% | -18,59% |
Omzet 2024 * | 189 mln. 177 mln. | Omzet 2025 * | 165 mln. 155 mln. | Marktkapitalisatie | 1,41 mld. 1,32 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -325 mln. -304 mln. | Nettowinst (verlies) 2025 * | -382 mln. -357 mln. | EV/omzet 2024 * | 4,26 x |
Nettoliquiditeiten 2024 * | 610 mln. 570 mln. | Nettoliquiditeiten 2025 * | 270 mln. 252 mln. | EV/omzet 2025 * | 6,92 x |
K/w-verhouding 2024 * |
-4,04
x | K/w-verhouding 2025 * |
-3,64
x | Werknemers | 577 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 58,87% |
Recentste transcriptie over Arcus Biosciences, Inc.
1 dag | +5,57% | ||
1 week | +6,58% | ||
Lopende maand | -17,64% | ||
1 maand | -6,61% | ||
3 maanden | +2,78% | ||
6 maanden | -2,32% | ||
Lopend jaar | -18,59% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Juan Jaen
FOU | Founder | 66 | 01-01-15 |
Terry Rosen
CEO | Chief Executive Officer | 64 | 01-01-15 |
Robert Goeltz
DFI | Director of Finance/CFO | 51 | 01-08-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Terry Rosen
CEO | Chief Executive Officer | 64 | 01-01-15 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 18-09-17 |
Yasunori Kaneko
BRD | Director/Board Member | 69 | 01-05-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.88% | 11 M€ | -6,03% | - | |
0.28% | 27 M€ | -5,03% | - | |
0.12% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 15,55 | +5,57% | 505 353 |
25-04-24 | 14,73 | -4,54% | 475 001 |
24-04-24 | 15,43 | -0,45% | 524 078 |
23-04-24 | 15,5 | +5,59% | 582 461 |
22-04-24 | 14,68 | +0,62% | 450 974 |
uitgestelde koers Nyse, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,59% | 1,34 mld. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |